Pharmaceuticals

Global Ankylosing Spondylitis Market 2015-2019

  • TEC169838
  • 102 Pages
  • January 2015
  • Pharmaceuticals
About Ankylosing Spondylitis
Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and chest expansion. Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in the vertebral column severely. It is a progressive inflammatory disease that typically becomes evident during early to mid-adulthood, as per NORD. It can also lead to the loss of spinal mobility for the affected individuals. The cause of the disease is not known, however, the HLA-B27 gene plays a major role. Ankylosing spondylitis is hereditary in nature.
TechNavio's analysts forecast the Global Ankylosing Spondylitis market to grow at a CAGR of 5.05 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Ankylosing Spondylitis market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of ankylosing spondylitis. The market is segmented based on the mechanism of action of the drugs used to treat ankylosing spondylitis as illustrated below:
TNF Inhibitors
COX Inhibitors
Others
On the type of molecule used for the treatment of ankylosing spondylitis, as illustrated below:
Biologics
Small Molecules
On the basis of route of administration adopted for the treatment of ankylosing spondylitis, the Global Ankylosing Spondylitis market is segmented as follows:
Oral
Parenteral
In addition, the market is also bifurcated on the basis of dosage forms of the drugs used in the treatment of the disease:
Solid
Liquid
The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Also, the late-stage pipeline molecules developed for the treatment of Ankylosing Spondylitis have been discussed.
TechNavio's report, Global Ankylosing Spondylitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA; it also covers the Global Ankylosing Spondylitis market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.
Key Regions
Americas
APAC
EMEA
Key Vendors
Abbvie
Amgen
Janssen Pharmaceuticals
Merck & Co.
Pfizer
Other Prominent Vendors

Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltrion
Eisai
F. Hoffmann-La Roche
Merck Sharp & Dohme
Novartis
Otsuka Pharmaceutical
Regeneron Pharmaceuticals
Sanofi
Shanghai Pharmaceuticals
UCB

Market Driver
Presence of Unmet Need
For a full, detailed list, view our report
Market Challenge
Threat from Patent Expiry
For a full, detailed list, view our report
Market Trend
Market Dominance by Biologics
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Ovarian Cancer Drugs Market (Drugs and geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation

Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Paediatric Vaccine Market (Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins. The global paediatric vaccine market ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Veterinary/Animal Vaccines Market - Opportunities and Forecasts, 2015 - 2020

Veterinary/animal vaccines are injected to animals to improve health conditions, increase production of livestock in economical way and prevent transmission of infectious diseases. These vaccines provide immunity against bacterial, viral, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Histone Deacetylase Inhibitors Market - Analysis, Growth, Global Share, Industry Overview, Trends Opportunities and Forecast 2012 - 2020

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness of new ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Pharmaceutical Excipients Market - Opportunities and Forecasts, 2015 - 2020

Pharmaceuticals excipient is a substance added with an active ingredient during manufacturing process of a drug. It helps in long term stabilization, reduction of viscosity, and enhancement of solubility of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>